IP Library Granted Patent US 9,681,802
Granted Patent B2
US 9,681,802 · App. 14/831,678 · Granted Jun 20, 2017

Fast absolute-reflectance method for the determination of tear film lipid layer thickness

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,681,802
App. No.
14/831,678
Granted
Jun 20, 2017
Kind
B2
Abstract

A method for determining reflectivity of a tear film lipid layer of a patient and recommending a course of treatment based on the same. The method includes the steps of: measuring a tear film aqueous plus lipid layer relative reflectance spectrum using a wavelength-dependent optical interferometer; converting the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance spectrum; comparing the calculated absolute reflectance spectrum to a theoretical absolute lipid reflectance spectrum to determine a tear film lipid layer thickness; and determining a reflectivity value for the tear film lipid layer thickness at a first wavelength of light corresponding to ultraviolet, violet, or blue light.

Claims (50)

1. A method for determining reflectivity of a tear film lipid layer of a patient, comprising the steps of:

measuring a tear film aqueous plus lipid layer relative reflectance spectrum using a wavelength-dependent optical interferometer;

converting the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance spectrum;

comparing the calculated absolute reflectance spectrum to a theoretical absolute lipid reflectance spectrum to determine a tear film lipid layer thickness; and

determining a reflectivity value for the tear film lipid layer thickness at a first wavelength of light corresponding to ultraviolet, violet, or blue light.

2. The method of claim 1 , wherein the first wavelength of light corresponds to UVA light, and wherein the method further comprises

determining a reflectivity value for the tear film lipid layer thickness at a second wavelength of light corresponding to UVB light, a third wavelength of light corresponding to violet light, and a fourth wavelength of light corresponding to blue light,

adding together the reflectivity values for the first and second wavelengths to produce a UV light sum,

adding together the reflectivity values for the third and fourth wavelengths to produce a visible light sum, and

comparing the UV light sum and the visible light sum to reference values to identify an intraocular lens for attenuating or blocking at least one wavelength of light corresponding to ultraviolet, violet, or blue light.

3. The method of claim 2 , wherein the first wavelength of light is within the range of 320-400 nm, the second wavelength of light is within the range of 290-320 nm, the third wavelength of light is within the range of 400-440 nm, and the fourth wavelength of light is within the range of 440-500 nm.

4. The method of claim 1 , further comprising determining whether to provide a blue-blocking intraocular lens to the patient based on the reflectivity value.

5. The method of claim 4 , wherein if the tear film lipid layer thickness is between 0-10 nm or between 130-150 nm then the patient is provided with a blue-blocking intraocular lens.

6. The method of claim 1 , wherein the calculated absolute reflectance spectrum is calculated based on wavelength-dependent refractive indices for air, lipid, and aqueous phases and wherein the wavelength-dependent refractive indices for lipid are based upon a Sellmeier equation form.

7. The method of claim 1 , wherein the tear film aqueous plus lipid layer relative reflectance spectrum is measured relative to a reference material.

8. The method of claim 1 , wherein converting the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance spectrum comprises multiplying the measured tear film aqueous plus lipid layer relative reflectance spectrum at a plurality of wavelengths times an absolute reference spectrum for the reference material obtained at the plurality of wavelengths.

9. The method of claim 8 , wherein converting the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance lipid spectrum further comprises dividing by a correction factor to correct for differences between the theoretical absolute reflectance spectrum and the calculated absolute reflectance spectrum.

10. The method of claim 8 , wherein converting the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute lipid reflectance spectrum further comprises dividing by 100.

11. The method of claim 1 , wherein comparing the calculated absolute reflectance spectrum to a theoretical absolute reflectance lipid spectrum comprises iteratively comparing the calculated absolute reflectance spectrum to a plurality of theoretical absolute reflectance lipid spectra.

12. The method of claim 11 , wherein iteratively comparing the calculated absolute reflectance spectrum to a plurality of theoretical absolute reflectance lipid spectra comprises minimizing a sum of least squares differences between the calculated absolute reflectance spectrum and the theoretical absolute reflectance lipid spectra.

13. The method of claim 12 , wherein minimizing a sum of least squares differences comprises using a Levenburg-Marquardt algorithm.

14. The method of claim 11 , wherein iteratively comparing the calculated absolute reflectance spectrum to a plurality of theoretical absolute reflectance lipid spectra comprises starting the iteration with a theoretical absolute reflectance lipid spectrum for a 65 nm thick lipid layer.

15. The method of claim 1 , wherein comparing the calculated absolute reflectance spectrum to a theoretical absolute lipid reflectance spectrum does not include a comparison of the calculated absolute reflectance spectrum to a theoretical absolute aqueous reflectance spectrum to determine a tear film aqueous layer thickness and a comparison of the calculated absolute reflectance spectrum to a theoretical film stack to determine corneal surface refractive index.

16. The method of claim 1 , further comprising determining whether to administer an ophthalmic composition to the patient based on the reflectivity value.

17. The method of claim 1 , further comprising determining whether to prescribe eyewear with particular light transmission or light blocking properties based on the reflectivity value.

18. A system for determining reflectivity of a tear film lipid layer of a patient, comprising:

a wavelength-dependent optical interferometer; and

a controller in communication with the interferometer, the controller configured to

measure a tear film aqueous plus lipid layer relative reflectance spectrum using the interferometer,

convert the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance spectrum,

compare the calculated absolute reflectance spectrum to a theoretical absolute lipid reflectance spectrum to determine a tear film lipid layer thickness, and

determine a reflectivity value for the tear film lipid layer thickness at a first wavelength of light corresponding to ultraviolet, violet, or blue light.

19. The system of claim 18 , wherein the first wavelength of light corresponds to UVA light, and wherein the controller is further configured to

determine a reflectivity value for the tear film lipid layer thickness at a second wavelength of light corresponding to UVB light, a third wavelength of light corresponding to violet light, and a fourth wavelength of light corresponding to blue light,

add together the reflectivity values for the first and second wavelengths to produce a UV light sum,

add together the reflectivity values for the third and fourth wavelengths to produce a visible light sum, and

compare the UV light sum and the visible light sum to reference values to identify an intraocular lens for attenuating or blocking at least one wavelength of light corresponding to ultraviolet, violet, or blue light.

20. The system of claim 19 , wherein the first wavelength of light is within the range of 320-400 nm, the second wavelength of light is within the range of 290-320 nm, the third wavelength of light is within the range of 400-440 nm, and the fourth wavelength of light is within the range of 440-500 nm.

21. The system of claim 18 , wherein the controller is further configured to determine whether the patient should be provided with a blue-blocking intraocular lens based on the reflectivity value.

22. The system of claim 21 , wherein if the tear film lipid layer thickness is between 0-10 nm or between 130-150 nm then the patient is provided with a blue-blocking intraocular lens.

23. The system of claim 18 , wherein the calculated absolute reflectance spectrum is calculated based on wavelength-dependent refractive indices for air, lipid, and aqueous phases and wherein the wavelength-dependent refractive indices for lipid are based upon a Sellmeier equation form.

24. The system of claim 18 , wherein the tear film aqueous plus lipid layer relative reflectance spectrum is measured relative to a reference material.

25. The system of claim 18 , wherein the controller, in order to convert the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance spectrum, is further configured to multiply the measured tear film aqueous plus lipid layer relative reflectance spectrum at a plurality of wavelengths times an absolute reference spectrum for the reference material obtained at the plurality of wavelengths.

26. The system of claim 25 , wherein the controller, in order to convert the measured tear film aqueous plus lipid layer relative reflectance spectrum to a calculated absolute reflectance lipid spectrum, is further configured to divide by a correction factor to correct for differences between the theoretical absolute reflectance spectrum and the calculated absolute reflectance spectrum.

27. The system of claim 18 , wherein the controller, in order to compare the calculated absolute reflectance spectrum to a theoretical absolute reflectance lipid spectrum, is further configured to iteratively compare the calculated absolute reflectance spectrum to a plurality of theoretical absolute reflectance lipid spectra.

28. The system of claim 27 , wherein the controller, in order to iteratively compare the calculated absolute reflectance spectrum to a plurality of theoretical absolute reflectance lipid spectra, is further configured to minimize a sum of least squares differences between the calculated absolute reflectance spectrum and the theoretical absolute reflectance lipid spectra.

29. The system of claim 27 , wherein the controller, in order to iteratively compare the calculated absolute reflectance spectrum to a plurality of theoretical absolute reflectance lipid spectra, is further configured to start the iteration with a theoretical absolute reflectance lipid spectrum for a 65 nm thick lipid layer.

30. The system of claim 18 , wherein the controller, in order to compare the calculated absolute reflectance spectrum to a theoretical absolute lipid reflectance spectrum, is further configured not to include a comparison of the calculated absolute reflectance spectrum to a theoretical absolute aqueous reflectance spectrum to determine a tear film aqueous layer thickness and a comparison of the calculated absolute reflectance spectrum to a theoretical film stack to determine corneal surface refractive index.

31. The system of claim 18 , wherein the controller is further configured to indicate whether to administer an ophthalmic composition to the patient based on the reflectivity value.

32. The system of claim 18 , wherein the controller is further configured to indicate whether to prescribe eyewear with particular light transmission or light blocking properties based on the reflectivity value.

Assignments (2)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047151/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2016
From: HUTH, STANLEY W.; TRAN, DENISE
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 037751/0711 →